Hemorrhage Stroke Decision Making Model Based Deep Learning (BrainHemoAI System)
Construction of an Integrated Intelligent Model for Spontaneous Intracerebral Hemorrhage Based on Deep Learning
1 other identifier
observational
7,100
1 country
1
Brief Summary
Although hemorrhagic stroke also has the characteristics of high mortality and disability rates, and constitutes a major public health problem worldwide, there is a relative lack of in-depth research teams for hemorrhagic stroke in China. The current preoperative imaging evaluation of spontaneous cerebral hemorrhage is still limited to the traditional Tada formula, and there are subjective differences in diagnosis among different doctors, making it difficult to achieve homogenization in clinical decision-making. Hemorrhagic stroke is a common and frequently occurring disease in Jiangxi Province. Therefore, establishing a new diagnosis and treatment system focused on hemorrhagic stroke can not only fill the research gap in this field in China, improve the accuracy and homogeneity of hemorrhagic stroke diagnosis and treatment, but also promote related research progress to reduce the mortality and disability rates of this disease and improve the clinical prognosis of patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Sep 2022
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2022
CompletedFirst Submitted
Initial submission to the registry
April 29, 2026
CompletedFirst Posted
Study publicly available on registry
May 6, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 30, 2026
May 6, 2026
April 1, 2026
3.9 years
April 29, 2026
April 29, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Area Under Curve
90-day and 180-day mRS score, survival status, functional independence (Barthel index).
90-day and 180-day
Secondary Outcomes (1)
Sensitivity ,Specificity,True Positive Rate,False Positive Rate
Baseline (admission), 24 hours postoperatively, 3 days postoperatively, 7 days postoperatively, discharge, 90-day follow-up, 180-day follow-up
Interventions
Automatical diagnosis, treatment decision-making, and risk prediction after spontaneous intracerebral hemorrhage via a trained deep learning larger language model.
Eligibility Criteria
Spontaneous hemorrhagic stroke, including parenchymal hemorrhage, subarachnoid hemorrhage, intraventricular hemorrhage, and subdural hemorrhage(including chronic subdural hemorrhage).
You may qualify if:
- Age \>= 8 years old;
- Patients diagnosed with spontaneous hemorrhagic stroke based on medical history and auxiliary examinations;
- Received non-contrast computed tomography (NCCT) in the outpatient or emergency department;
- Treated in accordance with standard clinical guidelines during hospitalization;
- Have complete clinical data.
You may not qualify if:
- Had undergone surgical treatment in another hospital before admission;
- Was in a state of shock upon admission;
- Had severe heart, liver, or kidney dysfunction or other life-threatening systemic diseases;
- Died during hospitalization;
- Had an expected lifespan of less than six months or was unable to complete the study follow-up for other reasons.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Second Affiliated Hospital of Nanchang Universitylead
- Zhejiang Universitycollaborator
- Ganzhou City People's Hospitalcollaborator
- The First People's Hospital of Xiushuicollaborator
- Jiujiang No.1 People's Hospitalcollaborator
- Renmin Hospital of Wuhan Universitycollaborator
- First Affiliated Hospital of Gannan Medical Universitycollaborator
- First Affiliated Hospital of Zhejiang Universitycollaborator
Study Sites (1)
The Second Affiliated Hospital of Nanchang University
Nanchang, China
Related Publications (4)
Du S, Wu Y, Tao J, Shu L, Yan T, Xiao B, Lv S, Ye M, Gong Y, Zhu X, Hu P, Wu M. Development and Validation of Machine Learning Models for Outcome Prediction in Patients with Poor-Grade Aneurysmal Subarachnoid Hemorrhage Following Endovascular Treatment. Ther Clin Risk Manag. 2025 Mar 7;21:293-307. doi: 10.2147/TCRM.S504745. eCollection 2025.
PMID: 40071129RESULTHu P, Wu Y, Yan T, Shu L, Liu F, Xiao B, Ye M, Wu M, Lv S, Zhu X. Deep learning-based quantification of total bleeding volume and its association with complications, disability, and death in patients with aneurysmal subarachnoid hemorrhage. J Neurosurg. 2024 Mar 29;141(2):343-354. doi: 10.3171/2024.1.JNS232280. Print 2024 Aug 1.
PMID: 38552240RESULTHu P, Yan T, Xiao B, Shu H, Sheng Y, Wu Y, Shu L, Lv S, Ye M, Gong Y, Wu M, Zhu X. Deep learning-assisted detection and segmentation of intracranial hemorrhage in noncontrast computed tomography scans of acute stroke patients: a systematic review and meta-analysis. Int J Surg. 2024 Jun 1;110(6):3839-3847. doi: 10.1097/JS9.0000000000001266.
PMID: 38489547RESULTHu P, Zhou H, Yan T, Miu H, Xiao F, Zhu X, Shu L, Yang S, Jin R, Dou W, Ren B, Zhu L, Liu W, Zhang Y, Zeng K, Ye M, Lv S, Wu M, Deng G, Hu R, Zhan R, Chen Q, Zhang D, Zhu X. Deep learning-assisted identification and quantification of aneurysmal subarachnoid hemorrhage in non-contrast CT scans: Development and external validation of Hybrid 2D/3D UNet. Neuroimage. 2023 Oct 1;279:120321. doi: 10.1016/j.neuroimage.2023.120321. Epub 2023 Aug 11.
PMID: 37574119RESULT
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor, Chief Physician
Study Record Dates
First Submitted
April 29, 2026
First Posted
May 6, 2026
Study Start
September 1, 2022
Primary Completion (Estimated)
August 1, 2026
Study Completion (Estimated)
December 30, 2026
Last Updated
May 6, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will not share